---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-000363"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2023-01-03T23:59:59+00:00"
generated_at: "2026-06-20T20:48:17.013913+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals moves headquarters to Encinitas, CA effective Jan 1, 2023

## Summary
- Effective January 1, 2023, corporate headquarters relocated to 332 Encinitas Blvd, Suite 102, Encinitas, CA 92024.
- Telephone number remains unchanged at (781) 788-9043.
- Previous address was 1371 East 2100 South, Suite 200, Salt Lake City, UT 84105.

## SEC filing metadata
- accession: 0001104659-23-000363
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2023-01-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465923000363/0001104659-23-000363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465923000363/tm231320d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-000363
- JSON: https://secwatch.observer/filing/0001104659-23-000363.json
- Plain text: https://secwatch.observer/filing/0001104659-23-000363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.